Cellosaurus logo
expasy logo

Cellosaurus PRG-3/293T-Rex (CVCL_C4CU)

[Text version]
Cell line name PRG-3/293T-Rex
Accession CVCL_C4CU
Resource Identification Initiative To cite this cell line use: PRG-3/293T-Rex (RRID:CVCL_C4CU)
Comments Genetic integration: Method=Transfection/transduction; Gene=HGNC; 25993; PLPPR1.
Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
Transformant: NCBI_TaxID; 28285; Adenovirus 5.
Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_U427 (Flp-In-T-REx-293)
Sex of cell Female
Age at sampling Fetus
Category Transformed cell line
Publications

Patent=US20100111851
Aburatani H., Torisu Y., Funahashi S.-i.
Diagnosis and treatment of cancer by using anti-PRG-3 antibody.
Patent number US20100111851, 06-May-2010

Cross-references
Encyclopedic resources Wikidata; Q116050127
Entry history
Entry creation15-Dec-2022
Last entry update10-Sep-2024
Version number5